aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]
aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus Target Price from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of aTyr Pharma (NASDAQ:LIFE – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a $35.00 price target on the biotechnology company’s stock. Separately, StockNews.com lowered aTyr Pharma from a hold rating to a sell rating in a research […]